loading

Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
37.59%
2.379
3.812 1.195 2.512 2.589
Operating Income/Loss
37.59%
-2.379
-3.812 -1.195 -2.512 -2.589
Nonoperating Income/Loss
79.41%
0.007
0.034 0.063 0.079 0.106
Income/Loss From Continuing Operations Before Tax
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Net Income/Loss
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
-12.10 - - -
Diluted Average Shares
32,710%
3.281
0.01 3.228 - -
Diluted Earnings Per Share
38.46%
-0.72
-1.17 -0.35 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):